194 related articles for article (PubMed ID: 7848128)
1. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
[TBL] [Abstract][Full Text] [Related]
3. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
Eidelberg D; Takikawa S; Moeller JR; Dhawan V; Redington K; Chaly T; Robeson W; Dahl JR; Margouleff D; Fazzini E
Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.
Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
Ann Neurol; 1994 Aug; 36(2):166-75. PubMed ID: 8053652
[TBL] [Abstract][Full Text] [Related]
5. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
[TBL] [Abstract][Full Text] [Related]
6. Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
Wenning GK; Jäger R; Kendall B; Kingsley D; Daniel SE; Quinn NP
Mov Disord; 1994 May; 9(3):333-6. PubMed ID: 8041375
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
8. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
9. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
Gilman S; Frey KA; Koeppe RA; Junck L; Little R; Vander Borght TM; Lohman M; Martorello S; Lee LC; Jewett DM; Kilbourn MR
Ann Neurol; 1996 Dec; 40(6):885-92. PubMed ID: 9007093
[TBL] [Abstract][Full Text] [Related]
10. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
Burn DJ; Rinne JO; Quinn NP; Lees AJ; Marsden CD; Brooks DJ
Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography.
Gilman S; Markel DS; Koeppe RA; Junck L; Kluin KJ; Gebarski SS; Hichwa RD
Ann Neurol; 1988 Mar; 23(3):223-30. PubMed ID: 3259853
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.
Ozawa T; Paviour D; Quinn NP; Josephs KA; Sangha H; Kilford L; Healy DG; Wood NW; Lees AJ; Holton JL; Revesz T
Brain; 2004 Dec; 127(Pt 12):2657-71. PubMed ID: 15509623
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
Wenning GK; Ben Shlomo Y; Magalhães M; Daniel SE; Quinn NP
Brain; 1994 Aug; 117 ( Pt 4)():835-45. PubMed ID: 7922469
[TBL] [Abstract][Full Text] [Related]
14. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical FDG-PET and MRI findings of striatonigral system in multiple system atrophy with hemiparkinsonism.
Kato T; Kume A; Ito K; Tadokoro M; Takahashi A; Sakuma S
Radiat Med; 1992; 10(3):87-93. PubMed ID: 1509106
[TBL] [Abstract][Full Text] [Related]
16. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.
Lee JH; Kim TH; Mun CW; Kim TH; Han YH
J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683
[TBL] [Abstract][Full Text] [Related]
17. Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
Kim HW; Oh M; Oh JS; Oh SJ; Lee SJ; Chung SJ; Kim JS
PLoS One; 2017; 12(1):e0169928. PubMed ID: 28085923
[TBL] [Abstract][Full Text] [Related]
18. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
19. Distinct clinical features of predominant pre-synaptic and trans-synaptic nigrostriatal dysfunction in multiple system atrophy.
Ryu HS; Oh M; Oh JS; Moon H; Park KW; Lee C; You S; Kim MJ; Kim YJ; Kim J; Kim K; Kim JS; Chung SJ
J Neurol Sci; 2019 Jul; 402():100-106. PubMed ID: 31128455
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
